Overall Technical outlook

Price Summary

On 2026-06-03, GlaxoSmithKline Pharmaceuticals Limited's stock began at 2190.1, climbed to 2198.1, dropped to 2165.0, and had -0.42% to end at 2181.0, with a volume of 53249 shares.
The highest price the stock achieved in the past 52 weeks is 3466.2, while the lowest price it saw is 2181.0.

Technicals


Aroon: The current state of the AROON is neutral, with no clear trend direction indicated. This lack of directional bias suggests that the market may be in a phase of consolidation or uncertainty.
GLAXO aroon 1cd5e0
Aroon chart for GlaxoSmithKline Pharmaceuticals Limited


Bol. Bands: The BOLL BANDS is currently in a neutral position, offering no clear indication of movement up or down. This suggests that the market may be experiencing a period of equilibrium, with no strong trend in play.
GLAXO bbands 1cd5e0
Bolinger Bands chart for GlaxoSmithKline Pharmaceuticals Limited


Parabolic SAR: The PSAR remains in a bearish mode, setting a strong resistance level that could impede any upward trends. This resistance indicates that the market may struggle to break higher, reflecting ongoing bearish sentiment for GLAXO.
GLAXO psar 1cd5e0
Parabolic Stop and Reverse chart for GlaxoSmithKline Pharmaceuticals Limited


Stochastic: With the K-line positioned above the D-line and under 20 on the stochastic indicator, the market may be entering a bullish phase. This pattern indicates that the market could be preparing for an upward trend, emerging from a lower level. Investors might interpret this as a signal of potential growth for GlaxoSmithKline Pharmaceuticals Limited.
GLAXO stoch 1cd5e0
Stochastic chart for GlaxoSmithKline Pharmaceuticals Limited


Tripple Moving Agerage: A bullish trend is reflected in the alignment of the 20-50-100 period moving averages, though the slopes of the faster averages hint at a possible reversal. This weakening momentum suggests that while the overall trend is still upward, traders should be cautious of a potential shift in the near future.
GLAXO trippleSMA 1cd5e0
Tripple SMA chart for GlaxoSmithKline Pharmaceuticals Limited


The technical analysis of a company's stock performance is valuable, but only when considered in conjunction with the company's fundamentals. These fundamentals, including financial strength, earnings growth, and leadership, provide a foundation for understanding market movements. Additionally, industry trends and competitive pressures play an important role. By integrating both fundamental and technical analysis, one can better evaluate the company's true potential and make more informed investment decisions.